Regeneron Pharmaceuticals, Inc. today announced the first presentation of key secondary endpoints for an investigational…
A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup…
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy…
Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the…
Artificial intelligence (AI) has made a grand entrance into the public debate this year, but…
Women living and working in places with higher levels of fine particle air pollution are…
Since its introduction in 2015, a prediction tool developed by the European Society of Medical…
ESMO, the leading professional organisation for medical oncology, today announced the launch of a new…
More than 1.4 million men were diagnosed with prostate cancer in 2020 globally(1), but the…
